insights_auto
Why is HNSA down 3,43%?
Dive Deeperchevron_right
HNSA:STO
Hansa Biopharma AB
47,86 SEK
arrow_downward
-3,43%(-1,70) 1D
17 նոյ, 16:55:00 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HNSA...
Open
49,26 SEK
High
49,76 SEK
Low
47,50 SEK
Mkt. cap
4,87 մլրդ
Avg. vol.
712,68 հզր
Volume
1,06 մլն
52-wk high
51,65 SEK
52-wk low
23,52 SEK
EPS
-7,91 SEK
Shares outstanding
101,76 մլն
No. of employees
111
Open
49,26 SEK
High
49,76 SEK
Low
47,50 SEK
Mkt. cap
4,87 մլրդ
Avg. vol.
712,68 հզր
Volume
1,06 մլն
52-wk high
51,65 SEK
52-wk low
23,52 SEK
EPS
-7,91 SEK
Shares outstanding
101,76 մլն
No. of employees
111
News stories
From web sources and news partners
Investing.com UK
·
1 ժամ առաջ
Hansa Biopharma at Jefferies: transplant drug nears key U.S. test By Investing.com
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees111
Founded2007
Headquarters-
SectorHealth Care
Industry-
Websitehansabiopharma.com